Login to Your Account

No Effector, Better Effects

Unexpected Toxicity has Lessons for Making Bispecific Antibodies

By Anette Breindl
Science Editor

Monday, May 6, 2013

By taking a detailed look at toxicities of a bispecific antibody that targets the transferrin receptor to cross the blood-brain-barrier, researchers at Genentech Inc. have gained new insights into both "important safety concerns and potential mitigation strategies" for the therapeutic development of such antibodies.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription